Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long Term Follow-up Study of TScan TCR-T Products
Sponsor: TScan Therapeutics, Inc.
Summary
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
Official title: A Long-term Follow-up Study to Assess Safety in Participants Who Received an Investigational T-Cell Receptor Engineered T-Cell (TCR-T) Product
Key Details
Gender
All
Age Range
18 Years - 110 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-09-09
Completion Date
2040-09
Last Updated
2025-09-10
Healthy Volunteers
No
Interventions
Observational
Long Term Follow-Up for participants treated with TSC-100 or TSC-101 TCR-T products
Locations (2)
City of Hope
Duarte, California, United States
Mount Sinai
New York, New York, United States